Search

Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.

… Friday, January 1, 2021 In the spring of 2021, Mark Denisiuk began feeling unwell. He had a sore throat and was always congested. His doctor diagnosed a sinus infection. Then Mark started having night sweats and extreme fatigue. “In the past, I had always powered through any illness I had, but the night

Nine students will don caps and gowns to celebrate their academic achievements and receive their PhDs from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).

… Tuesday, May 29, 2018 Summary The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan Kettering will award doctorate degrees to nine students tomorrow. Founded in 2006, the school prepares the next generation of scientists to take on real-world clinical challenges through

Discover how Sunrise Association Day Camps are transforming summer for children affected by cancer.

… Tuesday, July 24, 2018 Summary Children with cancer can enjoy a traditional summer camp experience thanks to Sunrise Association. The group operates day camps for young people with cancer and their siblings, free of charge. Cancer robbed Zachary Levine of a summer. Then just five years old, he spent

Hear from GSK Alumni Lindsey, Prashant, and Theresa, as they share more about their experience and where their careers have taken them.

… Friday, October 8, 2021 Three graduates, three journeys Lindsay Lindsay LaFave and Ross Levine As an undergraduate student approaching graduation at the University of Michigan, Lindsay LaFave had a sense of what she wanted to do next but wasn’t sure where her new chapter would unfold. “I was looking

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, September 28, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Michel Sadelain, MD, PhD, Michel Sadelain Awarded 2024 Breakthrough Prize in Life Sciences Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.

… Wednesday, May 16, 2012 Screening lung cancer tumor samples for cancer-causing, or “driver,” genetic mutations can help physicians tailor patients’ treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.

… Thursday, September 18, 2014 Summary The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute. On Tuesday, more than 40 Memorial Sloan Kettering doctors, including President and CEO Craig B. Thompson and Physician-in-Chief

Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress cancer.

… Monday, February 1, 2010 Summary Cancer biologist Andrea Ventura is the incumbent of a Geoffrey Beene Junior Faculty Chair at the Sloan Kettering Institute, he devotes his research to the nascent field of microRNA expression, seeking to understand how these small RNAs act on genes to promote or suppress

Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.

… Monday, March 10, 2014 Summary Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors. Memorial Sloan Kettering researchers have shown that tiny particles can be manipulated to act like sponges, taking in drugs

MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.

… Friday, April 19, 2019 Summary MSK researchers are using computer algorithms and artificial intelligence to develop a new type of PET imaging. Recently, the first-ever image of a black hole was splashed across front pages and filled up news feeds around the world. The image was made in part thanks to